Alphadyne Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.5M Buy
15,400
+11,000
+250% +$11.2M 0.18% 103
2026
Q1
$4.05M Buy
4,400
+2,500
+132% +$2.53M 0.07% 330
2025
Q4
$2.04M Sell
1,900
-2,800
-60% -$2.68M 0.05% 339
2025
Q3
$3.59M Buy
4,700
+3,000
+176% +$2.23M 0.29% 85
2025
Q2
$1.33M Buy
+1,700
New +$1.32M 0.24% 31
2023
Q4
Sell
-18,800
Closed -$10.1M 106
2023
Q3
$10.1M Buy
18,800
+12,000
+176% +$6.18M 0.77% 30
2023
Q2
$3.19M Buy
+6,800
New +$2.85M 0.39% 25

Other funds holding LLY

Alphadyne Asset Management's LLY Position: Q2 2026 in Review

Alphadyne Asset Management sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 3,738 shares — an estimated $3.82M sold.

Alphadyne Asset Management first reported a position in LLY in Q2 2023 and held it in 4 quarters. The position peaked at $3.44M in Q1 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Alphadyne Asset Management reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Alphadyne Asset Management sold 3,738 Eli Lilly shares in Q2 2026, an estimated $3.82M.
  • Alphadyne Asset Management first reported a position in Eli Lilly in Q2 2023 and held it in 4 quarters.
  • Alphadyne Asset Management's Eli Lilly position peaked at $3.44M in Q1 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Alphadyne Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.